Next Article in Journal
Dietary Influences on the Microbiota–Gut–Brain Axis
Next Article in Special Issue
Temozolomide Induces the Acquisition of Invasive Phenotype by O6-Methylguanine-DNA Methyltransferase (MGMT)+ Glioblastoma Cells in a Snail-1/Cx43-Dependent Manner
Previous Article in Journal
Salubrinal Alleviates Collagen-Induced Arthritis through Promoting P65 Degradation in Osteoclastogenesis
Previous Article in Special Issue
An Update on Connexin Gap Junction and Hemichannels in Diabetic Retinopathy
Review

Mechanisms Underlying Connexin Hemichannel Activation in Disease

1
Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium
2
Department of Medical Imaging, In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium
3
Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Lih Kuo
Int. J. Mol. Sci. 2021, 22(7), 3503; https://doi.org/10.3390/ijms22073503
Received: 15 March 2021 / Revised: 22 March 2021 / Accepted: 26 March 2021 / Published: 28 March 2021
(This article belongs to the Special Issue Connexin and Pannexin Signaling in Health and Disease)
Gap junctions and connexin hemichannels mediate intercellular and extracellular communication, respectively. While gap junctions are seen as the “good guys” by controlling homeostasis, connexin hemichannels are considered as the “bad guys”, as their activation is associated with the onset and dissemination of disease. Open connexin hemichannels indeed mediate the transport of messengers between the cytosol and extracellular environment and, by doing so, fuel inflammation and cell death in a plethora of diseases. The present mini-review discusses the mechanisms involved in the activation of connexin hemichannels during pathology. View Full-Text
Keywords: connexin hemichannel; pathology; mechanism connexin hemichannel; pathology; mechanism
Show Figures

Graphical abstract

MDPI and ACS Style

Van Campenhout, R.; Gomes, A.R.; De Groof, T.W.M.; Muyldermans, S.; Devoogdt, N.; Vinken, M. Mechanisms Underlying Connexin Hemichannel Activation in Disease. Int. J. Mol. Sci. 2021, 22, 3503. https://doi.org/10.3390/ijms22073503

AMA Style

Van Campenhout R, Gomes AR, De Groof TWM, Muyldermans S, Devoogdt N, Vinken M. Mechanisms Underlying Connexin Hemichannel Activation in Disease. International Journal of Molecular Sciences. 2021; 22(7):3503. https://doi.org/10.3390/ijms22073503

Chicago/Turabian Style

Van Campenhout, Raf, Ana R. Gomes, Timo W.M. De Groof, Serge Muyldermans, Nick Devoogdt, and Mathieu Vinken. 2021. "Mechanisms Underlying Connexin Hemichannel Activation in Disease" International Journal of Molecular Sciences 22, no. 7: 3503. https://doi.org/10.3390/ijms22073503

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop